Search

Your search keyword '"Gilles Defraene"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Gilles Defraene" Remove constraint Author: "Gilles Defraene"
95 results on '"Gilles Defraene"'

Search Results

1. The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment

2. A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer

3. Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases

4. External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort

5. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients

6. Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer

7. Stroke rate after external fractionated radiotherapy for benign meningioma

8. The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment

9. Ga-68-PSMA-11 PET, F-18-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability

10. Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer

11. A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer

12. Multifactorial risk factors for mortality after chemotherapy and radiotherapy for non-small cell lung cancer

13. Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres

14. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

15. NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer

16. Low-dose CT allows for accurate proton therapy dose calculation and plan optimization

17. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

18. OC-0631 Proton and photon treatment planning comparison for oesophageal cancer between six European centres

20. PD-0818 Dose prediction with deep learning: the effect of data quality and quantity in the model’s accuracy

21. PD-0881 Deep learning dose prediction as a tool to evaluate treatment complications based on NTCP models

22. Deep learning dose prediction for IMRT of esophageal cancer: The effect of data quality and quantity on model performance

23. Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases

24. Regional lung avoidance by CT numbers to reduce radiation-induced lung damage risk in non-small-cell lung cancer: a simulation study

25. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection

26. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

27. Development and internal validation of a multinomial NTCP model for the severity of acute dyspnea after radiotherapy for lung cancer

28. Validation of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy

29. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study

30. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements

31. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy

32. Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume

34. CT characteristics allow identification of patient-specific susceptibility for radiation-induced lung damage

35. Online adaptation and verification of VMAT

36. Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study

37. Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures

38. PV-0100: Impact of lung dose on postoperative complications after trimodality treatment in esophageal cancer

41. Peripheral doses in radiotherapy: A comparison between IMRT, VMAT and Tomotherapy

42. Characterization of OSL Al2O3:C droplets for medical dosimetry

43. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement

44. Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study

45. Regional variability in radiation-induced lung damage can be predicted by baseline CT numbers

46. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements

47. Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system

49. EP-1419: Optimal design and patient selection for interventional trials using radiogenomic biomarkers

50. Heart radiation dose as a risk factor for dyspnea worsening after multimodality treatment for non-small cell lung cancer and pleural mesothelioma: An exploratory analysis

Catalog

Books, media, physical & digital resources